… did not impact survival outcomes in the Low-ER group of our study 18,25,26,27 . Survival
analysis by endocrine therapy use in our study was limited by small numbers of patients, and …

… estrogen receptor nor progesterone receptor or both were significant predictors of survival.
Only … positive receptor content improved survival for early stage I and II patients but decreased …

… Moreover, a recent observational study found that survival in 33 patients with poorly
differentiated OCas correlated with higher serum progesterone, especially in combination with …

… Among all the factors affecting overall survival (SV) and disease-free survival (DFS), the …
The prognostic value of estrogen receptors (ER) and/or progesterone receptors (PR) still is a …

… (individually and combinations of ER−/PR−, ER+/PR−, ER−/PR+, and ER+/PR+) were
correlated with standard prognostic factors of overall survival (OS) in this patient population. …

… Kaplan-Meier survival curves of estrogen receptor–and/or progesterone receptor–positive …
the 822-gene estrogen–significance analysis of microarrays–derived list. Survival curves are …

… that prior postmenopausal estrogen replacement therapy does not compromise survival in
… estrogen? In addition, we sought to determine whether estrogen and progesterone receptor …

… However, it is not known whether tissue sampling of metastatic sites has any significant
effect on patient survival or quality of life [13, 14] and whether the biology of the primary or the …

… Conversely, early initiation of chemotherapy did not significantly improve disease-free
survival for patients with tumors expressing ER. No data are available in the literature on the …

… Survival and our ability to predict survival for BCBM patients are … of patients who gained
estrogen or progesterone receptors (change from negative to positive) and only 32% of patients …